Stoke Therapeutics, Inc. STOK Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Stoke Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The official record: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Stoke Therapeutics, Inc.'s operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Stoke Therapeutics, Inc.'s operating lease liabilities (total)?
- Stoke Therapeutics, Inc. (STOK) reported operating lease liabilities (total) of $3.42M in Q1 2026.
- How has Stoke Therapeutics, Inc.'s operating lease liabilities (total) changed year-over-year?
- Stoke Therapeutics, Inc.'s operating lease liabilities (total) decreased by 42.5% year-over-year, from $5.95M to $3.42M.
- What is the long-term trend for Stoke Therapeutics, Inc.'s operating lease liabilities (total)?
- Over 5 years (2020 to 2025), Stoke Therapeutics, Inc.'s operating lease liabilities (total) has grown at a 29.3% compound annual growth rate (CAGR), from $1.15M to $4.15M.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.